- Home
- TSHA vs LE Comparison
TSHA vs LE Comparison
Compare TSHA & LE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSHA
- LE
- Stock Information
- Founded
- TSHA 2019
- LE 1963
- Country
- TSHA United States
- LE United States
- Employees
- TSHA N/A
- LE N/A
- Industry
- TSHA Biotechnology: Pharmaceutical Preparations
- LE Clothing/Shoe/Accessory Stores
- Sector
- TSHA Health Care
- LE Consumer Discretionary
- Exchange
- TSHA Nasdaq
- LE Nasdaq
- Market Cap
- TSHA 334.1M
- LE 357.5M
- IPO Year
- TSHA 2020
- LE N/A
- Fundamental
- Price
- TSHA $1.61
- LE $11.30
- Analyst Decision
- TSHA Strong Buy
- LE Strong Buy
- Analyst Count
- TSHA 8
- LE 2
- Target Price
- TSHA $6.63
- LE $20.00
- AVG Volume (30 Days)
- TSHA 2.1M
- LE 81.0K
- Earning Date
- TSHA 02-26-2025
- LE 03-26-2025
- Dividend Yield
- TSHA N/A
- LE N/A
- EPS Growth
- TSHA N/A
- LE N/A
- EPS
- TSHA N/A
- LE N/A
- Revenue
- TSHA $9,915,000.00
- LE $1,436,124,000.00
- Revenue This Year
- TSHA N/A
- LE N/A
- Revenue Next Year
- TSHA N/A
- LE $1.97
- P/E Ratio
- TSHA N/A
- LE N/A
- Revenue Growth
- TSHA N/A
- LE N/A
- 52 Week Low
- TSHA $1.19
- LE $7.64
- 52 Week High
- TSHA $4.32
- LE $19.88
- Technical
- Relative Strength Index (RSI)
- TSHA 46.14
- LE 35.22
- Support Level
- TSHA $1.46
- LE $11.15
- Resistance Level
- TSHA $1.76
- LE $11.97
- Average True Range (ATR)
- TSHA 0.15
- LE 0.44
- MACD
- TSHA 0.01
- LE 0.01
- Stochastic Oscillator
- TSHA 39.33
- LE 26.98
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.
About LE Lands' End Inc.
Lands' End Inc is a United States-based multi-channel retailer of casual clothing, accessories, and footwear, as well as home products. The company's operating segment includes U.S. eCommerce; International; Outfitters; Third Party and Retail. It generates maximum revenue from the U.S. eCommerce segment. The U.S. eCommerce segment offers products through the company's eCommerce website. Geographically, it derives a majority of its revenue from the United States.